SEC Form 4 · accession 0001623919-16-000039
EndoChoice Holdings, Inc. · GI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David L Kaufman
Director
Period of report
Mar 11, 2016
Accepted (ET)
Mar 14, 2016 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1,F2 | Mar 11, 2016 | P | 89,450 | $4.806 | A | 2,088,209 | I | By Envest III, LLC |
| Common stock, par value $0.001 per share | holding | — | — | — | 5,625 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging, inclusively, from $4.70 to $4.855 per share on purchases reported for March 11, 2016. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- F2The reporting person is a Founder and Senior Managing Director of Envest Holdings LLC and as a result may be deemed to beneficially own the shares owned by Envest Holdings or related entities. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.